Related references
Note: Only part of the references are listed.Superior Graft-versus-Leukemia Effect Associated with Transplantation of Haploidentical Compared with HLA-Identical Sibling Donor Grafts for High-Risk Acute Leukemia: An Historic Comparison
Yu Wang et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Biology, Risk Stratification, and Therapy of Pediatric Acute Leukemias: An Update
Ching-Hon Pui et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Modern Therapy of Acute Lymphoblastic Leukemia
Renato Bassan et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
High CD4/CD8 ratio in allografts predicts adverse outcomes in unmanipulated HLA-mismatched/haploidentical hematopoietic stem cell transplantation for chronic myeloid leukemia
Lan-Ping Xu et al.
ANNALS OF HEMATOLOGY (2009)
Platelet Engraftment in Patients with Hematologic Malignancies following Unmanipulated Haploidentical Blood and Marrow Transplantation: Effects of CD34+ Cell Dose and Disease Status
Ying-Jun Chang et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
The impact of graft composition on clinical outcomes in unmanipulated HLA-mismatched/haploidentical hematopoietic SCT
X-H Luo et al.
BONE MARROW TRANSPLANTATION (2009)
Partially Matched Related Donor Transplantation Can Achieve Outcomes Comparable with Unrelated Donor Transplantation for Patients with Hematologic Malignancies
Huang Xiao-Jun et al.
CLINICAL CANCER RESEARCH (2009)
The Impact of CD34+ Cell Dose on Platelet Engraftment in Pediatric Patients Following Unmanipulated Haploidentical Blood and Marrow Transplantation
Ying-Jun Chang et al.
PEDIATRIC BLOOD & CANCER (2009)
Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for treatment of hematological malignancies in children
Daihong Liu et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Allo-SCT in children with high-risk leukemia using unmanipulated grafts from alternative donors
P. Sedlacek et al.
BONE MARROW TRANSPLANTATION (2008)
Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) bone marrow transplantation using only pharmacological GVHD prophylaxis
Hiroyasu Ogawa et al.
EXPERIMENTAL HEMATOLOGY (2008)
CD3+ cell dose and disease status are important factors determining clinical undergoing unmanipulated outcomes in patients haploidentical blood and including marrow transplantation after conditioning antithymocyte globulin
Lujia Dong et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
Maintaining hyporesponsiveness and polarization potential of T cells after in vitro mixture of G-CSF mobilized peripheral blood grafts and G-CSF primed bone marrow grafts in different proportions
Xiao-Jun Huang et al.
TRANSPLANT IMMUNOLOGY (2007)
Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies
X. -J. Huang et al.
BONE MARROW TRANSPLANTATION (2006)
Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation
DP Lu et al.
BLOOD (2006)
Low-dose methotrexate for the treatment of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
XJ Huang et al.
BONE MARROW TRANSPLANTATION (2005)
CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling transplantation
JM Zaucha et al.
BLOOD (2001)
Granulocyte-colony-stimulating factor (G-CSF)-primed allogeneic bone marrow: significantly less graft-versus-host disease and comparable engraftment to G-CSF-mobilized peripheral blood stem cells
J Morton et al.
BLOOD (2001)
Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers.
WI Bensinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
The number of donor CD3+ cells is the most important factor for graft failure after allogeneic transplantation of CD34+ selected cells from peripheral blood from HLA-identical siblings
A Urbano-Ispizua et al.
BLOOD (2001)
Immunobiology of allogeneic peripheral blood mononuclear cells mobilized with granulocyte-colony stimulating factor
M Gyger et al.
BONE MARROW TRANSPLANTATION (2000)
Share Paper
